| Pharmaceutical active ingredients: |
| Levodopa |
| Available forms, composition and doses of Larodopa: |
| Capsules; Oral; Levodopa 100 mgCapsules; Oral; Levodopa 250 mgCapsules; Oral; Levodopa 500 mgTablets; Oral; Levodopa 100 mgTablets; Oral; Levodopa 250 mgTablets; Oral; Levodopa 500 mg |
| Larodopa medical category: |
| Human:Antiparkinsonian drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N04BA01 - Levodopa |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| RocheCambridge Laboratories |